22 – 24/09/2023

Hermes Hotel, ERMOUPOLIS, SYROS ISLAND

IASIS PHARMA participated in the “Developments in Dermatology & Venereology 2023” conference which held on September 22-24 2023, at the Hermes Hotel in Syros Island.

The conference was organized by the Hellenic College of Dermatology-Venereology with the scientific support of the 2nd Clinic of Venereology and Skin Diseases of U.O.A.

Dermatologists from all over Greece who attended the Conference had the chance to visit IASIS PHARMA exhibition stand and informed of IASIS major Dermatological products:

• Isotroin^®/Isotretinoin (in the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy.
• Combi^®, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses.
• Modiwart^®/Ιmiquimod, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.

During the conference, IASIS PHARMA organized a Satellite Lecture, entitled:

The Value of Isotretinoin: “Advances in the Systemic Treatment of Acne”

–  Chair: Dr N. Stavrianeas, Emeritus Professor of Dermatology of the University of Athens.

–  Speaker: Dr A. Katoulis, Professor of Dermatology-Venereology School of Medicine, U.O.A., Professor and Chairman 2nd Dept. of Dermatology and Venereology Attikon University Hospital.